Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin
- 1 February 2005
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 37 (2) , 142-145
- https://doi.org/10.1080/00365540410020776-1
Abstract
Continuous intravenous colistin (2,000,000 units per 24 h) was administered in a 41-y-old patient with Acinetobacter baumannii bacteraemia, which led to the cure of the infection. The isolated microorganism was a multi-resistant strain (it was sensitive only to colistin). In addition, the patient had developed allergic reactions to previously administered antimicrobial agents of several classes during his hospitalization. Continuous intravenous infusion of colistin proved to be a salvage regimen, which led to cure of a bacteraemia due to a multi-resistant isolate, without showing any allergic cross-reactivity with other antibiotics.Keywords
This publication has 7 references indexed in Scilit:
- Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosaClinical Infectious Diseases, 2003
- Treatment of Multidrug‐ResistantAcinetobacter baumanniiVentilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAPClinical Infectious Diseases, 2003
- Colistin: An Antimicrobial for the 21st Century?Clinical Infectious Diseases, 2002
- Cerebrospinal Fluid Penetration and Pharmacokinetic/Pharmacodynamic Parameters of Intravenously Administered Colistin in a Case of Multidrug-Resistant Acinetobacter baumannii MeningitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Cost‐Effectiveness of Ceftazidime by Continuous Infusion versus Intermittent Infusion for Nosocomial PneumoniaPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998
- Continuous infusion of beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1992